Original Research
Published on 19 Oct 2022
Putting external validation performance of major bleeding risk models into context
in Cardiovascular Drug Safety
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2022.1034677
- 588 views
Type at least 3 characters
62 articles
Articles
Original Research
Published on 10 Oct 2022
Effectiveness and tolerability of Poliprotect, a natural mucosal protective agent for gastroesophageal reflux disease and dyspepsia: Surveys from patients, physicians, and pharmacists
in Substance-Based Medical Devices
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2022.969831
- 4,655 views
- 4 citations
Perspective
Published on 16 Sep 2022
New regulation on medical devices made of substances: Opportunities and challenges for pharmacological and toxicological research
in Substance-Based Medical Devices
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2022.1001614
- 1,362 views
- 3 citations
Perspective
Published on 02 Sep 2022
Substance-based medical devices made of natural substances: An opportunity for therapeutic innovation
in Substance-Based Medical Devices
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2022.998114
- 2,879 views
- 4 citations
Opinion
Published on 15 Aug 2022
Towards a European harmonization of health technology assessment recommendations executive paper of European regulatory conference focused on the EU commission proposal to harmonize HTA
in Advanced Methods in Pharmacovigilance and Pharmacoepidemiology
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2022.970661
- 2,190 views
- 4 citations
Perspective
Published on 04 Jul 2022
Medical Devices Made of Substances: A New Challenge
in Substance-Based Medical Devices
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2022.952013
- 5,741 views
- 4 citations
Perspective
Published on 28 Jun 2022
Medical Devices Made of Substances: The Need for a Change in Approach in Paediatrics
in Substance-Based Medical Devices
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2022.867143
- 3,353 views
- 2 citations
Mini Review
Published on 27 Jun 2022
Pharmacological Versus Non-Pharmacological and Ancillary Mechanisms in Eye Drops Used in the Treatment of Glaucoma
in Substance-Based Medical Devices
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2022.933471
- 2,376 views
- 1 citation
Brief Research Report
Published on 15 Jun 2022
Increased Confidence in Deduplication of Drug Safety Reports with Natural Language Processing of Narratives at the US Food and Drug Administration
in Advanced Methods in Pharmacovigilance and Pharmacoepidemiology
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2022.918897
- 2,741 views
- 4 citations
Mini Review
Published on 08 Jun 2022
Digital Therapeutics in Perspective: From Regulatory Challenges to Post-Marketing Surveillance
in Substance-Based Medical Devices
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2022.900946
- 7,110 views
- 15 citations
Systematic Review
Published on 24 May 2022
Efficacy and Safety of a Polysaccharide-Based Natural Substance Complex in the Treatment of Obesity and Other Metabolic Syndrome Components: A Systematic Review
in Substance-Based Medical Devices
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2022.844256
- 2,404 views
- 5 citations
Specialty Grand Challenge
Published on 05 Apr 2022
Current Status and Future Challenges in the Treatment of Rheumatic Diseases
in Rheumatic Drug Safety
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2022.881556
- 2,876 views
- 3 citations
Field Grand Challenge
Published on 25 Feb 2022
A New Era of Pharmacovigilance: Future Challenges and Opportunities
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2022.866898
- 32,959 views
- 25 citations
Specialty Grand Challenge
Published on 29 Oct 2021
Moving to a Personalized Approach in Respiratory Medicine. From Academic Research to Regulatory Intervention
in Respiratory Drug Safety
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2021.752581
- 1,686 views
- 3 citations